Enovis Corp, trading under the symbol ENOV, is a dynamic company that embodies the spirit of technological innovation, providing pioneering solutions to specific industry needs. Established by a team of seasoned experts, Enovis Corp specializes in developing state-of-the-art software systems, offering high-quality services to businesses across the globe. The company's commitment to address its clients' unique challenges and deliver customized systems sets it apart, positioning itself as the go-to option for groundbreaking, out-of-the-box software solutions.
At Enovis Corp, the belief is that technology is not just an instrument but a transformational entity that drives growth, fosters efficiency, and empowers businesses to reach their full potential. The company has embodied this belief in its diverse offerings such as digital transformation, software development services, and business intelligence solutions.
With offices in several countries worldwide, Enovis Corp possesses a global perspective, an essential factor in its success. This diversified perspective enables the company to understand the unique needs of markets across regions, thus designing software solutions that address these specific needs. With a team comprised of subject matter experts and IT professionals, Enovis Corp harnesses collective experience and expertise to come up with industry-leading solutions.
Enovis Corp (ENOV) prides itself on its core values which include supreme quality, professionalism, innovation, and continuous improvement with a customer-centered approach. The company’s principle is to approach each project with a fresh perspective, reaching beyond traditional methodologies to deliver efficient and cost-effective solutions.
ENOV's growth trajectory has been predominantly upward, a testament to the effectiveness of its strategy. Its innovative solutions have continued to gain acceptance across all sectors, resulting in robust performance indicators year upon year. Despite entering a highly competitive market, Enovis Corp has carved its place, and now stands as a beacon of innovation and efficiency.
Enovis Corp's commitment to its customers does not end with the delivery of the software system; it extends into after-service, offering comprehensive training and support packages to ensure seamless usage. With its finger always on the pulse of the industry, the company stays at the forefront of emerging technologies, ensuring its clients always remain competitive.
Simply put, Enovis Corp is not just a software company. It is a catalyst, a partner, and an architect of progress that uses technology to create solutions transforming the way businesses operate. As the company continues to grow, so does its ambition - to go beyond traditional boundaries, push limits, and redefine what is possible in the world of technology.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends

Enovis Corporation Director Sharon L. Wienbar recently acquired 1,831 shares of the company's common stock through two open-market transactions on November 6 and November 9, 2026. These purchases increased her direct ownership to 43,777 shares. The transactions, reported via a Form 4 to the SEC on November 10, 2026, were executed at prices of $27.55 and $26.98 per share, respectively.

Enovis (NYSE:ENOV) reported strong Q3 2026 results, with sales growth on both reported and organic bases, driven by significant market share gains in its Reconstructive segment. The company also raised its full-year guidance for adjusted EBITDA and adjusted EPS, reflecting confidence in margin improvement and successful execution of its innovation-led strategy. This performance highlights Enovis's ability to capitalize on steady demand from an aging population and advancements in orthopedic medical technology.

Enovis reported strong third-quarter 2026 results, with sales up 2% year-over-year to $559 million and organic growth of 5%, driven by Recon and PNR segments. The company is set to acquire Essential Robotics by year-end, aiming to introduce knee and shoulder robots within two years, and has authorized a $200 million share repurchase program. Enovis raised its full-year guidance for adjusted EPS to between $3.58 and $3.79 and expects revenue in the range of $2.32 to $2.35 billion, with approximately 5% organic growth.

Argus has raised its target price for Enovis Corporation (ENOV) stock to $20.00. Enovis Corp is a medical technology company providing devices and services for patient care, from injury prevention to rehabilitation. The current price for ENOV is $21.08.

Enovis (ENOV) is garnering fresh attention as its upcoming investor call on November 5, 2026, approaches, set to review third-quarter results. Despite recent share price weakness, with a 40.4% drop over the last year, analysts suggest the stock is 54% undervalued, estimating a fair value around $38.33. This valuation is driven by an expanding orthopedic market, Enovis's focus on innovative technologies, and projected earnings growth from a current loss to a profit by 2029, though significant forecast dispersion exists.